StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Evolva Holding S.A.
Swiss Stock Exchange:EVE.SW
Sector
Location
Market Cap
USD 9.80 M
Share Price
USD 1.36
Avg Daily Volume
22,438
Change (1 day)
-1.36%
Change (1 year)
Change (YTD)
12.20%
Evolva Holding S.A. EBITDA for the year ending December 31, 2023: USD -116.82 M
Evolva Holding S.A. EBITDA is USD -116.82 M for the year ending December 31, 2023, a 212.97% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Evolva Holding S.A. EBITDA for the year ending December 31, 2022 was USD -37.33 M, a 7.02% change year over year.
-
Evolva Holding S.A. EBITDA for the year ending December 31, 2021 was USD -34.88 M, a 49.91% change year over year.
-
Evolva Holding S.A. EBITDA for the year ending December 31, 2020 was USD -23.27 M, a 70.98% change year over year.
-
Evolva Holding S.A. EBITDA for the year ending December 31, 2019 was USD -13.61 M, a -48.01% change year over year.
Competitors
Bayer AG
USD 32.50
BAYN.DE
+0.47
1.47%
Symrise AG
USD 106.47
SY1.DE
+0.10
0.09%
Puig Brands S.A.
USD 19.77
PUIG.MC
+0.45
2.31%
Roivant Sciences Ltd.
USD 11.57
ROIV
+0.35
3.12%
ALK-Abelló A/S
USD 30.58
ALK-B.CO
+0.59
1.96%
Inter Parfums, Inc.
USD 136.49
IPAR
+1.47
1.09%
PharmaResearch Co., Ltd.
USD 406.73
214450.KQ
-23.33
-5.42%
Bloomage BioTechnology Corporation Limited
USD 7.19
688363.SS
+0.04
0.62%
Almirall, S.A.
USD 12.87
ALM.MC
+0.12
0.93%
Robertet S.A.
USD 953.51
RBT.PA
+11.26
1.20%
AMOREPACIFIC Group
USD 23.78
002790.KS
+0.50
2.16%
Tarsus Pharmaceuticals, Inc.
USD 41.16
TARS
-0.13
-0.32%
Johnson & Johnson
USD 157.69
JNJ
+1.41
0.90%
The Procter & Gamble Company
USD 158.49
PG
+0.97
0.62%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
USD 590.82
MC.PA
+19.09
3.34%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
L'Oréal S.A.
USD 447.21
OR.PA
+8.49
1.94%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Bayer AG
USD 32.50
BAYN.DE
+0.47
1.47%
Symrise AG
USD 106.47
SY1.DE
+0.10
0.09%
Puig Brands S.A.
USD 19.77
PUIG.MC
+0.45
2.31%
Roivant Sciences Ltd.
USD 11.57
ROIV
+0.35
3.12%
ALK-Abelló A/S
USD 30.58
ALK-B.CO
+0.59
1.96%
Inter Parfums, Inc.
USD 136.49
IPAR
+1.47
1.09%
PharmaResearch Co., Ltd.
USD 406.73
214450.KQ
-23.33
-5.42%
Bloomage BioTechnology Corporation Limited
USD 7.19
688363.SS
+0.04
0.62%
Almirall, S.A.
USD 12.87
ALM.MC
+0.12
0.93%
Robertet S.A.
USD 953.51
RBT.PA
+11.26
1.20%
AMOREPACIFIC Group
USD 23.78
002790.KS
+0.50
2.16%
Tarsus Pharmaceuticals, Inc.
USD 41.16
TARS
-0.13
-0.32%
Johnson & Johnson
USD 157.69
JNJ
+1.41
0.90%
The Procter & Gamble Company
USD 158.49
PG
+0.97
0.62%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
USD 590.82
MC.PA
+19.09
3.34%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
L'Oréal S.A.
USD 447.21
OR.PA
+8.49
1.94%